These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 27792713)

  • 1. [Assessment and intervention thresholds to detect cases at risk of osteoporosis and fragility fractures with FRAX® in a mexican population for the first level of healthcare].
    Clark P; Ramírez-Pérez E; Reyes-López A
    Gac Med Mex; 2016 Oct; 152(Suppl 2):22-31. PubMed ID: 27792713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [FRAX® thresholds to identify people with high or low risk of osteoporotic fracture in Spanish female population].
    Azagra R; Roca G; Martín-Sánchez JC; Casado E; Encabo G; Zwart M; Aguyé A; Díez-Pérez A;
    Med Clin (Barc); 2015 Jan; 144(1):1-8. PubMed ID: 24461732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of a FRAX-based intervention threshold in Turkey: the FRAX-TURK study.
    Tuzun S; Eskiyurt N; Akarirmak U; Saridogan M; Johansson H; McCloskey E; Kanis JA;
    Arch Osteoporos; 2012; 7():229-35. PubMed ID: 23060308
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Osteoporosis - whom to treat? The importance of FRAX® in Switzerland].
    Lippuner K
    Ther Umsch; 2012 Mar; 69(3):207-13. PubMed ID: 22403115
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The utility of dual-energy X-ray absorptiometry, calcaneal quantitative ultrasound, and fracture risk indices (FRAX® and Osteoporosis Risk Assessment Instrument) for the identification of women with distal forearm or hip fractures: A pilot study.
    Esmaeilzadeh S; Cesme F; Oral A; Yaliman A; Sindel D
    Endocr Res; 2016 Aug; 41(3):248-60. PubMed ID: 26864472
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FRAX-based intervention and assessment thresholds for osteoporosis in Romania.
    Grigorie D; Sucaliuc A; Johansson H; Kanis JA; McCloskey E
    Arch Osteoporos; 2013; 8():164. PubMed ID: 24390553
    [TBL] [Abstract][Full Text] [Related]  

  • 7. FRAX and the assessment of the risk of developing a fragility fracture.
    Middleton RG; Shabani F; Uzoigwe CE; Shoaib A; Moqsith M; Venkatesan M
    J Bone Joint Surg Br; 2012 Oct; 94(10):1313-20. PubMed ID: 23015554
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The application of FRAX® to determine intervention thresholds in osteoporosis treatment in Poland.
    Badurski JE; Kanis JA; Johansson H; Dobreńko A; Nowak NA; Daniluk S; Jezienicka E
    Pol Arch Med Wewn; 2011 May; 121(5):148-55. PubMed ID: 21610662
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of clinical risk factors for osteoporosis and applicability of the FRAX tool in Joinville City, Southern Brazil.
    Silva DMW; Borba VZC; Kanis JA
    Arch Osteoporos; 2017 Dec; 12(1):111. PubMed ID: 29224172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The distribution of FRAX(®)-based probabilities in women from Japan.
    Kanis JA; Johansson H; Odén A; McCloskey EV
    J Bone Miner Metab; 2012 Nov; 30(6):700-5. PubMed ID: 22911378
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Incidence of hip fracture in Brazil and the development of a FRAX model.
    Zerbini CA; Szejnfeld VL; Abergaria BH; McCloskey EV; Johansson H; Kanis JA
    Arch Osteoporos; 2015; 10():224. PubMed ID: 26303038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Primary care use of FRAX: absolute fracture risk assessment in postmenopausal women and older men.
    Siris ES; Baim S; Nattiv A
    Postgrad Med; 2010 Jan; 122(1):82-90. PubMed ID: 20107292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Agreement of Mexican FRAX with and without the value of bone mineral density in assessing the risk of fracture in daily clinical practice.
    Horta-Baas G; Pérez Bolde-Hernández A; Pérez-Pérez A; Vergara-Sánchez I; Romero-Figueroa MDS
    Med Clin (Barc); 2017 May; 148(9):387-393. PubMed ID: 28118961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Assessment of a set of FRAX(®)-based criteria for the indication of bone densitometry in Spanish postmenopausal women].
    Gómez-Vaquero C; Roig-Vilaseca D; Bianchi M; Santo P; Narváez J; Nolla JM
    Med Clin (Barc); 2013 May; 140(10):439-43. PubMed ID: 22578993
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The activity of a Spanish bone densitometry unit revisited under the point of view of FRAX.
    Gómez-Vaquero C; Bianchi M; Santo P; Roig-Vilaseca D; Narváez J; Nolla JM
    Reumatol Clin; 2012; 8(4):179-83. PubMed ID: 22608955
    [TBL] [Abstract][Full Text] [Related]  

  • 16. clinical risk factors for osteoporosis in Ireland and the UK: a comparison of FRAX and QFractureScores.
    Cummins NM; Poku EK; Towler MR; O'Driscoll OM; Ralston SH
    Calcif Tissue Int; 2011 Aug; 89(2):172-7. PubMed ID: 21647704
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Fragility fracture in the Chronic Kidney Disease (CKD)].
    Fusaro M; Aghi A; Mereu MC; Giusti A
    G Ital Nefrol; 2017 Dec; 34(Nov-Dec):. PubMed ID: 29207223
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Development of Novel Osteoporosis Screening Methods Using FRAX].
    Yamamoto N; Tsuchiya H
    Yakugaku Zasshi; 2019; 139(1):35-38. PubMed ID: 30606925
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Intervention Thresholds for the Treatment of Osteoporosis Based on FRAX(®) in Portugal.
    Marques A; Lourenço Ó; Ortsäter G; Borgström F; Kanis JA; da Silva JA
    Calcif Tissue Int; 2016 Aug; 99(2):131-41. PubMed ID: 27016370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Managing osteoporosis with FRAX® in Australia: proposed new treatment thresholds from the 45&Up Study cohort.
    Chen JS; Simpson JM; Blyth FM; March LM
    Bone; 2014 Dec; 69():148-53. PubMed ID: 25263521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.